Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With IPAA

Inclusion Criteria: * Patient is male or female between the ages of 18-75 years, inclusive. * Patient has history of UC or Crohn's disease (CD) diagnosed by standard clinical, radiographic, endoscopic, and histopathological criteria. * Patient has undergone total proctocolectomy and IPAA surgery a minimum of 6 months prior to screening. * Patient has symptoms suggestive of pouchitis including frequent bowel movements of greater than or equal to seven per day (≥7 per day), and one or more of the following: daily rectal bleeding, fecal urgency, abdominal cramps, or fever \>37.8oC). * Patient is capable of understanding the requirements of the study and has signed / dated an IRB approved informed consent form. Exclusion Criteria: * Patient cannot or will not provide written informed consent. * Patient has a known allergy or hypersensitivity to beef, beef products, or any ingredient used in EnteraGam. * Patient has clinical signs and symptoms of an active infection. * Patient is on antibiotic therapy (other than for pouchitis treatment) at any time in the 30 days prior to screening. * Patient has active alcohol or drug abuse or psychiatric disorders felt to preclude his / her ability to complete the study. * Patient who, in the opinion of the investigator, has a poorly controlled / uncontrolled significant medical condition that would interfere with the study. * Positive stool test (PCR) for C. difficile. * Use of antidiarrheal medications (ADM). - Exception: patients who, in …